In a mouse melanoma model, Quezada et al. reported that tumor-specific CD4+ T cells acquired a similar polyfunctional phenotype in postradiotherapy hosts [66], suggesting that the immunogenic milieu created by chemotherapy or radiotherapy may share some common features in terms of driving CD4+ T-cell effector differentiation. Here, CD4 is linked to melanoma.